Table 12:
Characteristics of Studies Included in the Economic Systematic Review
| Author, year, country, intervention, comparator | Analysis | Study population | Results | |||||
|---|---|---|---|---|---|---|---|---|
| Technique | Design (model) | Approach or perspective | Time horizon (discount rate) | Health outcomes | Costs | Cost-effectiveness | ||
| Kumar et al, 2019,94 US | Threshold analysis | Decision tree | Societal | 1 y (N/A) | Patients with treatment-refractory OCD considered suitable candidates for surgery | — | Currency, cost year: USD, 2017 | ICER not reported; study concluded that MRgFUS neurosurgery was cost-effective under a range of possible values, and results were most sensitive to cost, effectiveness, and complication rate of MRgFUS neurosurgery. PSA was not reported. |
| I: MRgFUS neurosurgery | — | — | — | — | NR | NR | ||
| C: RFA | 0.212 QALYs | $24,099 USD | ||||||
Abbreviations: C, comparator; I, intervention; ICER, incremental cost-effectiveness ratio; MRgFUS, magnetic resonance-guided focused ultrasound; N/A, not applicable; NR, not reported; OCD, obsessive–compulsive disorder; PSA, probabilistic sensitivity analysis; QALY, quality-adjusted life-year; RFA, radiofrequency ablation.